Parallel Session 2201

From Mechanisms to Management: Integrating Digital Tools in the Assessment and Treatment of Gait Disorders in Parkinson’s Disease

Saturday, February 14, 2026
14:30 - 16:30 | Houston Ballroom

In this session, the faculty will address the clinical and pathophysiological features of gait disorders in Parkinson’s disease, with particular focus on freezing of gait and the application of technology. The session will include an overview of current models, examine the role of wearable sensors and digital tools in the assessment of gait, and present evidence-based, non-pharmacological strategies for the management of gait and balance dysfunction.

Chairs:

Catalina Cerquera-Cleves, Canada
Gonzalo Revuelta, USA

Presenters:

Pathophysiological Pathways of Freezing of Gait in Parkinson’s Disease
Gonzalo Revuelta, USA

Wearables and Digital Biomarkers for Gait Assessment in Parkinson’s Disease
Martina Mancini, USA

Non-Pharmacological and Technology-Assisted Interventions to Improve Gait and Balance in Parkinson’s Disease
Tamine Capato, Brazil

CSPC Liaisons:

Catalina Cerquera-Cleves, Canada
Charles Adler, USA

Learning Objectives

At the conclusion of this session, participants should be better able to:

1. Describe the underlying pathophysiological mechanisms of gait impairment and freezing of gait in Parkinson’s disease, highlighting the role of non-dopaminergic contributors.
2. Critically evaluate the utility, limitations, and future direction of wearable technologies and digital biomarkers for objective gait analysis in Parkinson’s disease.
3. Discuss current evidence supporting non-pharmacological interventions for improving gait and balance in Parkinson’s disease, including digital technologies and robotic-assisted rehabilitation.

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Researcher / Basic Science

Education Level

Beginner / Foundational
Experienced
Expert